145 related articles for article (PubMed ID: 11504792)
1. Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion.
Schriefer JA; Broudy EP; Hassen AH
J Pharmacol Exp Ther; 2001 Sep; 298(3):970-5. PubMed ID: 11504792
[TBL] [Abstract][Full Text] [Related]
2. Endopeptidase inhibitors decrease myocardial ischemia/reperfusion injury in an in vivo rabbit model.
Schriefer JA; Broudy EP; Hassen AH
J Pharmacol Exp Ther; 1996 Sep; 278(3):1034-9. PubMed ID: 8819483
[TBL] [Abstract][Full Text] [Related]
3. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
4. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.
Hartman JC; Kurc GM; Hullinger TG; Wall TM; Sheehy RM; Shebuski RJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):1071-6. PubMed ID: 7523655
[TBL] [Abstract][Full Text] [Related]
6. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.
Hartman JC; Wall TM; Hullinger TG; Shebuski RJ
J Cardiovasc Pharmacol; 1993 Jun; 21(6):996-1003. PubMed ID: 7687728
[TBL] [Abstract][Full Text] [Related]
7. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor.
Freise H; Palmes D; Spiegel HU
J Surg Res; 2006 Aug; 134(2):231-7. PubMed ID: 16513137
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide- and prostaglandin-mediated cardioprotection by bradykinin in myocardial ischemia and reperfusion injury.
Veeravalli KK; Akula A; Kota MK
Pol J Pharmacol; 2003; 55(6):1021-9. PubMed ID: 14730097
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury.
Casillas-Ramirez A; Amine-Zaouali M; Massip-Salcedo M; Padrissa-Altés S; Bintanel-Morcillo M; Ramalho F; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
Crit Care Med; 2008 Apr; 36(4):1256-66. PubMed ID: 18379253
[TBL] [Abstract][Full Text] [Related]
11. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
Rao Y; Wang YL; Zhang WS; Liu J
Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
[TBL] [Abstract][Full Text] [Related]
12. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
[TBL] [Abstract][Full Text] [Related]
13. [Reduction of infarct size and remodeling after ramipril].
Martorana PA; Linz W; Schölkens BA
Z Kardiol; 1994; 83 Suppl 4():63-4. PubMed ID: 7856282
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotection of bradykinin at reperfusion involves transactivation of the epidermal growth factor receptor via matrix metalloproteinase-8.
Methner C; Donat U; Felix SB; Krieg T
Acta Physiol (Oxf); 2009 Dec; 197(4):265-71. PubMed ID: 19583703
[TBL] [Abstract][Full Text] [Related]
15. Studies on the involvement of bradykinin using enalapril and 2-mercaptoethanol in ischemia-reperfusion induced myocardial infarction in albino rats.
Akula A; Veeravalli KK; Kota MK; Routhu KV
Pharmazie; 2003 Dec; 58(12):906-9. PubMed ID: 14703971
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of effects of verapamil and those of nicardipine on myocardial ischemia and reperfusion injury: a study in an in situ rabbit model].
Furuya M; Yoshida K
Masui; 1999 Oct; 48(10):1074-82. PubMed ID: 10554498
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts.
Hatta E; Maruyama R; Marshall SJ; Imamura M; Levi R
J Pharmacol Exp Ther; 1999 Mar; 288(3):919-27. PubMed ID: 10027827
[TBL] [Abstract][Full Text] [Related]
18. Effects of neutral endopeptidase 24.11 inhibition on myocardial infarct size and ischemic preconditioning in rabbits.
Nakano A; Miura T; Miki T; Nozawa Y; Ichikawa Y; Ura N; Shimamoto K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):335-42. PubMed ID: 12237747
[TBL] [Abstract][Full Text] [Related]
19. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
[TBL] [Abstract][Full Text] [Related]
20. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
